Affimed Historical Financial Ratios

AFMD Stock

USD 3.00 0.38 14.50%

Affimed NV is presently reporting on over 121 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 1.87 or Days Sales Outstanding of 247 will help investors to properly organize and evaluate Affimed NV financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.

About Affimed Financial Ratios Analysis

Affimed NVFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Affimed NV investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Affimed financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Affimed NV history.

Affimed NV Financial Ratios Chart

At present, Affimed NV's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 1.36, whereas Book Value Per Share is forecasted to decline to 2.02.

Price To Sales Ratio Capex To Depreciation Pb Ratio Roic Capex To Revenue Cash Per Share

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Affimed NV stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Affimed NV sales, a figure that is much harder to manipulate than other Affimed NV multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most ratios from Affimed NV's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Affimed NV current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.At present, Affimed NV's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 1.36, whereas Book Value Per Share is forecasted to decline to 2.02.

	2021	2022	2023	2024 (projected)
Graham Number	35.1	38.21	24.85	45.14
Receivables Turnover	8.39	15.33	1.55	1.48

Graham Number Receivables Turnover

Affimed NV fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Net Income Per Share	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow	Earnings Yield	Intangibles To Total Assets
Price To Sales Ratio		-0.67	0.52	-0.69	0.34	0.1	-0.57	-0.67	0.98	0.11	0.65	0.12	-0.28	-0.54	-0.45	0.35	0.39	-0.47	0.08	0.64	-0.83	-0.09	-0.46	-0.83	0.38	0.89
Ptb Ratio	-0.67		-0.61	0.81	0.1	0.14	0.51	1.0	-0.71	0.13	-0.36	0.53	0.03	0.8	0.14	-0.58	-0.37	0.15	0.27	-0.36	0.57	-0.29	0.81	0.57	0.13	-0.74
Days Sales Outstanding	0.52	-0.61		-0.42	-0.54	-0.31	0.01	-0.61	0.52	-0.31	-0.22	-0.24	0.61	-0.76	0.11	0.33	0.04	0.1	-0.04	-0.23	-0.24	0.07	-0.39	-0.24	-0.55	0.38
Book Value Per Share	-0.69	0.81	-0.42		-0.22	-0.22	0.49	0.81	-0.74	-0.23	-0.51	0.33	0.2	0.83	0.45	-0.33	-0.24	0.46	0.2	-0.55	0.8	-0.19	0.92	0.8	-0.16	-0.9
Free Cash Flow Yield	0.34	0.1	-0.54	-0.22		0.65	-0.4	0.1	0.3	0.65	0.83	0.36	-0.84	0.29	-0.48	0.0	0.38	-0.48	0.1	0.83	-0.47	-0.17	-0.05	-0.47	0.96	0.39
Operating Cash Flow Per Share	0.1	0.14	-0.31	-0.22	0.65		-0.09	0.14	0.11	1.0	0.34	0.39	-0.35	0.08	-0.05	0.0	0.49	-0.04	-0.05	0.35	-0.15	-0.04	-0.05	-0.15	0.46	0.17
Capex To Depreciation	-0.57	0.51	0.01	0.49	-0.4	-0.09		0.51	-0.57	-0.11	-0.68	0.09	0.65	0.22	0.6	-0.05	-0.55	0.61	-0.11	-0.68	0.69	0.12	0.41	0.69	-0.44	-0.61
Pb Ratio	-0.67	1.0	-0.61	0.81	0.1	0.14	0.51		-0.71	0.13	-0.36	0.53	0.03	0.8	0.14	-0.58	-0.37	0.15	0.27	-0.36	0.57	-0.29	0.81	0.57	0.13	-0.74
Ev To Sales	0.98	-0.71	0.52	-0.74	0.3	0.11	-0.57	-0.71		0.13	0.6	0.05	-0.29	-0.59	-0.41	0.33	0.43	-0.42	-0.04	0.61	-0.82	0.03	-0.5	-0.83	0.33	0.92
Free Cash Flow Per Share	0.11	0.13	-0.31	-0.23	0.65	1.0	-0.11	0.13	0.13		0.35	0.39	-0.36	0.07	-0.06	0.0	0.51	-0.06	-0.05	0.37	-0.16	-0.04	-0.06	-0.16	0.47	0.19
Roic	0.65	-0.36	-0.22	-0.51	0.83	0.34	-0.68	-0.36	0.6	0.35		0.1	-0.8	-0.03	-0.65	0.25	0.44	-0.66	0.14	0.99	-0.76	-0.17	-0.39	-0.76	0.85	0.69
Net Income Per Share	0.12	0.53	-0.24	0.33	0.36	0.39	0.09	0.53	0.05	0.39	0.1		-0.15	0.36	-0.01	-0.1	0.03	-0.01	0.63	0.16	0.05	-0.67	0.6	0.05	0.43	-0.15
Capex To Revenue	-0.28	0.03	0.61	0.2	-0.84	-0.35	0.65	0.03	-0.29	-0.36	-0.8	-0.15		-0.29	0.48	0.03	-0.45	0.48	-0.03	-0.82	0.46	0.06	0.06	0.46	-0.87	-0.39
Cash Per Share	-0.54	0.8	-0.76	0.83	0.29	0.08	0.22	0.8	-0.59	0.07	-0.03	0.36	-0.29		0.12	-0.33	-0.06	0.13	0.15	-0.09	0.5	-0.17	0.79	0.5	0.34	-0.66
Pocfratio	-0.45	0.14	0.11	0.45	-0.48	-0.05	0.6	0.14	-0.41	-0.06	-0.65	-0.01	0.48	0.12		0.33	0.08	1.0	-0.22	-0.65	0.83	0.22	0.42	0.83	-0.57	-0.59
Interest Coverage	0.35	-0.58	0.33	-0.33	0.0	0.0	-0.05	-0.58	0.33	0.0	0.25	-0.1	0.03	-0.33	0.33		0.23	0.32	0.16	0.25	-0.06	-0.16	-0.35	-0.06	-0.03	0.22
Capex To Operating Cash Flow	0.39	-0.37	0.04	-0.24	0.38	0.49	-0.55	-0.37	0.43	0.51	0.44	0.03	-0.45	-0.06	0.08	0.23		0.07	-0.19	0.41	-0.22	0.13	-0.1	-0.23	0.27	0.35
Pfcf Ratio	-0.47	0.15	0.1	0.46	-0.48	-0.04	0.61	0.15	-0.42	-0.06	-0.66	-0.01	0.48	0.13	1.0	0.32	0.07		-0.21	-0.65	0.84	0.21	0.42	0.83	-0.56	-0.6
Income Quality	0.08	0.27	-0.04	0.2	0.1	-0.05	-0.11	0.27	-0.04	-0.05	0.14	0.63	-0.03	0.15	-0.22	0.16	-0.19	-0.21		0.19	-0.06	-1.0	0.25	-0.05	0.23	-0.17
Roe	0.64	-0.36	-0.23	-0.55	0.83	0.35	-0.68	-0.36	0.61	0.37	0.99	0.16	-0.82	-0.09	-0.65	0.25	0.41	-0.65	0.19		-0.77	-0.23	-0.4	-0.77	0.86	0.7
Ev To Operating Cash Flow	-0.83	0.57	-0.24	0.8	-0.47	-0.15	0.69	0.57	-0.82	-0.16	-0.76	0.05	0.46	0.5	0.83	-0.06	-0.22	0.84	-0.06	-0.77		0.06	0.67	1.0	-0.51	-0.93
Pe Ratio	-0.09	-0.29	0.07	-0.19	-0.17	-0.04	0.12	-0.29	0.03	-0.04	-0.17	-0.67	0.06	-0.17	0.22	-0.16	0.13	0.21	-1.0	-0.23	0.06		-0.26	0.06	-0.27	0.16
Return On Tangible Assets	-0.46	0.81	-0.39	0.92	-0.05	-0.05	0.41	0.81	-0.5	-0.06	-0.39	0.6	0.06	0.79	0.42	-0.35	-0.1	0.42	0.25	-0.4	0.67	-0.26		0.67	0.03	-0.73
Ev To Free Cash Flow	-0.83	0.57	-0.24	0.8	-0.47	-0.15	0.69	0.57	-0.83	-0.16	-0.76	0.05	0.46	0.5	0.83	-0.06	-0.23	0.83	-0.05	-0.77	1.0	0.06	0.67		-0.51	-0.93
Earnings Yield	0.38	0.13	-0.55	-0.16	0.96	0.46	-0.44	0.13	0.33	0.47	0.85	0.43	-0.87	0.34	-0.57	-0.03	0.27	-0.56	0.23	0.86	-0.51	-0.27	0.03	-0.51		0.39
Intangibles To Total Assets	0.89	-0.74	0.38	-0.9	0.39	0.17	-0.61	-0.74	0.92	0.19	0.69	-0.15	-0.39	-0.66	-0.59	0.22	0.35	-0.6	-0.17	0.7	-0.93	0.16	-0.73	-0.93	0.39

Click cells to compare fundamentals

Affimed NV Account Relationship Matchups

Affimed NV fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	7.34	14.02	14.37	3.99	10.21	9.7
Ptb Ratio	4.09	4.06	5.52	4.27	1.08	1.87
Days Sales Outstanding	25.29	31.39	43.48	23.8	234.97	246.72
Book Value Per Share	6.02	8.62	11.38	10.74	3.87	2.02
Free Cash Flow Yield	(0.19)	(0.0499)	(0.16)	(0.64)	(1.35)	(1.28)
Operating Cash Flow Per Share	(4.52)	(2.32)	(7.25)	(7.37)	(7.38)	(7.75)
Stock Based Compensation To Revenue	0.97	0.0857	0.12	0.46	1.29	1.36
Capex To Depreciation	1.63	0.39	2.89	0.24	2.13	2.24
Pb Ratio	4.09	4.06	5.52	4.27	1.08	1.87
Ev To Sales	3.03	8.88	9.94	(0.17)	7.89	7.5
Free Cash Flow Per Share	(4.75)	(2.38)	(7.57)	(7.42)	(7.63)	(8.01)
Roic	(0.79)	(0.48)	(0.42)	(0.55)	(1.52)	(1.45)
Net Income Per Share	(5.04)	(4.96)	(4.81)	(6.04)	(7.09)	(7.45)
Research And Ddevelopement To Revenue	2.05	1.76	2.02	2.39	11.48	12.05
Capex To Revenue	0.0689	0.0155	0.0954	0.0168	0.45	0.47
Cash Per Share	16.21	17.59	16.54	13.37	4.88	4.64
Pocfratio	(5.4)	(20.49)	(6.7)	(1.57)	(0.77)	(0.8)
Interest Coverage	(67.03)	(365.45)	(89.93)	(54.06)	(59.06)	(62.01)
Capex To Operating Cash Flow	(0.0507)	(0.0227)	(0.0445)	(0.006635)	(0.0338)	(0.0355)
Pfcf Ratio	(5.14)	(20.03)	(6.41)	(1.56)	(0.74)	(0.78)
Income Quality	0.9	0.47	1.51	1.22	1.04	0.99
Roe	(0.84)	(0.57)	(0.42)	(0.56)	(1.83)	(1.74)
Ev To Operating Cash Flow	(2.23)	(12.99)	(4.63)	0.069	(0.59)	(0.62)
Pe Ratio	(4.85)	(9.61)	(10.08)	(1.92)	(0.8)	(0.84)
Return On Tangible Assets	(0.17)	(0.29)	(0.24)	(0.43)	(1.09)	(1.15)
Ev To Free Cash Flow	(2.13)	(12.7)	(4.44)	0.0685	(0.57)	(0.6)
Earnings Yield	(0.21)	(0.1)	(0.0992)	(0.52)	(1.25)	(1.19)
Intangibles To Total Assets	0.001219	0.009777	0.007138	2.89E-4	2.57E-4	2.44E-4
Net Debt To E B I T D A	2.97	4.25	2.8	2.11	0.19	0.18
Tangible Book Value Per Share	6.0	8.42	11.24	10.74	3.87	1.97
Receivables Turnover	14.43	11.63	8.39	15.33	1.55	1.48
Graham Number	26.12	31.01	35.1	38.21	24.85	45.14
Shareholders Equity Per Share	6.02	8.62	11.38	10.74	3.87	2.02
Debt To Equity	0.0616	0.004487	0.13	0.0388	0.21	0.22
Capex Per Share	0.23	0.0527	0.32	0.0489	0.25	0.26
Graham Net Net	4.93	5.4	9.39	10.19	2.53	2.65
Revenue Per Share	3.33	3.4	3.38	2.9	0.55	0.53
Interest Debt Per Share	0.93	0.45	0.0501	1.54	0.53	0.89

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:

How To Invest In Affimed

Details

Is Affimed Stock a good investment?

Details

What is Affimed NV's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.76)

Revenue Per Share

0.493

Quarterly Revenue Growth

(0.90)

Return On Assets

(0.49)

Return On Equity

(1.24)

The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Affimed Historical Financial Ratios

About Affimed Financial Ratios Analysis

Affimed NV Financial Ratios Chart

Price To Sales Ratio

Capex To Depreciation

Roic

Capex To Revenue

Affimed NV fundamentals Correlations

Affimed NV Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Affimed NV fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Ev To Free Cash Flow	+ 1.0	Ev To Operating Cash Flow
Roe	+ 0.99	Roic
Ev To Sales	+ 0.98	Price To Sales Ratio

Pe Ratio	- 1.0	Income Quality
Intangibles To Total Assets	- 0.93	Ev To Free Cash Flow
Intangibles To Total Assets	- 0.93	Ev To Operating Cash Flow
Intangibles To Total Assets	- 0.9	Book Value Per Share
Earnings Yield	- 0.87	Capex To Revenue
Capex To Revenue	- 0.84	Free Cash Flow Yield